FIELD: biotechnology.
SUBSTANCE: antibody to PD-1, its antigen-binding fragment, a pharmaceutical composition containing an antibody to PD-1 and its antigen-binding fragment, a nucleic acid molecule encoding an antibody to PD-1 or its antigen-binding fragment. In particular, a host cell for producing an antibody to PD-1 or an antigen-binding fragment thereof and a method for treating diseases associated with PD-1 are proposed.
EFFECT: used for the treatment of cancer.
20 cl, 3 dwg, 21 tbl, 7 ex
